146 related articles for article (PubMed ID: 27864802)
1. Secreted Phospholipase A2 Type IIA (sPLA2-IIA) Activates Integrins in an Allosteric Manner.
Takada Y; Fujita M
Adv Exp Med Biol; 2017; 925():103-115. PubMed ID: 27864802
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1.
Fujita M; Zhu K; Fujita CK; Zhao M; Lam KS; Kurth MJ; Takada YK; Takada Y
J Biol Chem; 2015 Jan; 290(1):259-71. PubMed ID: 25398877
[TBL] [Abstract][Full Text] [Related]
3. Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner.
Saegusa J; Akakura N; Wu CY; Hoogland C; Ma Z; Lam KS; Liu FT; Takada YK; Takada Y
J Biol Chem; 2008 Sep; 283(38):26107-15. PubMed ID: 18635536
[TBL] [Abstract][Full Text] [Related]
4. Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin αvβ3.
Ye L; Dickerson T; Kaur H; Takada YK; Fujita M; Liu R; Knapp JM; Lam KS; Schore NE; Kurth MJ; Takada Y
Bioorg Med Chem Lett; 2013 Jan; 23(1):340-5. PubMed ID: 23164706
[TBL] [Abstract][Full Text] [Related]
5. The CD9, CD81, and CD151 EC2 domains bind to the classical RGD-binding site of integrin αvβ3.
Yu J; Lee CY; Changou CA; Cedano-Prieto DM; Takada YK; Takada Y
Biochem J; 2017 Feb; 474(4):589-596. PubMed ID: 27993971
[TBL] [Abstract][Full Text] [Related]
6. AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs.
El Hadri K; Denoyelle C; Ravaux L; Viollet B; Foretz M; Friguet B; Rouis M; Raymondjean M
PLoS One; 2015; 10(7):e0132498. PubMed ID: 26162096
[TBL] [Abstract][Full Text] [Related]
7. Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells.
Dong Z; Meller J; Succop P; Wang J; Wikenheiser-Brokamp K; Starnes S; Lu S
Int J Oncol; 2014 Sep; 45(3):978-84. PubMed ID: 24913497
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Human Group IIA-Secreted Phospholipase A2 and THP-1 Monocyte Recruitment by Maslinic Acid.
Yap WH; Ahmed N; Lim YM
Lipids; 2016 Oct; 51(10):1153-1159. PubMed ID: 27540737
[TBL] [Abstract][Full Text] [Related]
9. Respective contribution of cytosolic phospholipase A2α and secreted phospholipase A
Duchez AC; Boudreau LH; Naika GS; Rousseau M; Cloutier N; Levesque T; Gelb MH; Boilard E
Prostaglandins Other Lipid Mediat; 2019 Aug; 143():106340. PubMed ID: 31129176
[TBL] [Abstract][Full Text] [Related]
10. Characterization of secretory type IIA phospholipase A2 (sPLA2-IIA) as a glycyrrhizin (GL)-binding protein and the GL-induced inhibition of the CK-II-mediated stimulation of sPLA2-IIA activity in vitro.
Shimoyama Y; Sakamoto R; Akaboshi T; Tanaka M; Ohtsuki K
Biol Pharm Bull; 2001 Sep; 24(9):1004-8. PubMed ID: 11558558
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD40L activates soluble and cell-surface integrin αvβ3, α5β1, and α4β1 by binding to the allosteric ligand-binding site (site 2).
Takada YK; Shimoda M; Maverakis E; Felding BH; Cheng RH; Takada Y
J Biol Chem; 2021; 296():100399. PubMed ID: 33571526
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulations reveal structural insights into inhibitor binding modes and functionality in human Group IIA phospholipase A
Kim RR; Malde AK; Nematollahi A; Scott KF; Church WB
Proteins; 2017 May; 85(5):827-842. PubMed ID: 28056488
[TBL] [Abstract][Full Text] [Related]
13. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
Fujita M; Takada YK; Takada Y
PLoS One; 2014; 9(5):e96372. PubMed ID: 24789099
[TBL] [Abstract][Full Text] [Related]
14. Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA.
Duchez AC; Boudreau LH; Naika GS; Bollinger J; Belleannée C; Cloutier N; Laffont B; Mendoza-Villarroel RE; Lévesque T; Rollet-Labelle E; Rousseau M; Allaeys I; Tremblay JJ; Poubelle PE; Lambeau G; Pouliot M; Provost P; Soulet D; Gelb MH; Boilard E
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3564-73. PubMed ID: 26106157
[TBL] [Abstract][Full Text] [Related]
15. Virtual Screening of Protein Data Bank via Docking Simulation Identified the Role of Integrins in Growth Factor Signaling, the Allosteric Activation of Integrins, and P-Selectin as a New Integrin Ligand.
Takada Y; Fujita M; Takada YK
Cells; 2023 Sep; 12(18):. PubMed ID: 37759488
[TBL] [Abstract][Full Text] [Related]
16. Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells.
Jaulmes A; Janvier B; Andreani M; Raymondjean M
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1161-7. PubMed ID: 15802623
[TBL] [Abstract][Full Text] [Related]
17. Secreted group IIA phospholipase A2 protects humans against the group B streptococcus: experimental and clinical evidence.
Movert E; Wu Y; Lambeau G; Kahn F; Touqui L; Areschoug T
J Infect Dis; 2013 Dec; 208(12):2025-35. PubMed ID: 23901095
[TBL] [Abstract][Full Text] [Related]
18. Secretory phospholipase A
Chovatiya GL; Sarate RM; Sunkara RR; Gawas NP; Kala V; Waghmare SK
Sci Rep; 2017 Sep; 7(1):11619. PubMed ID: 28912581
[TBL] [Abstract][Full Text] [Related]
19. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
[TBL] [Abstract][Full Text] [Related]
20. Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes.
Triggiani M; Granata F; Oriente A; Gentile M; Petraroli A; Balestrieri B; Marone G
Eur J Immunol; 2002 Jan; 32(1):67-76. PubMed ID: 11754005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
